Umecrine Cognition is developing pharmaceuticals against neurological disorders in the central nervous system, CNS. The company is focused on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease and for treatment of excessive daytime sleepiness in patients with idiopathic hypersomnia.
Location: Burkina Faso, Sahel, Solna
Investors 3
| Date | Name | Website |
| - | Almi Inves... | almi.se |
| - | Fort Knox | fort-knox.... |
| - | Karolinska... | karolinska... |
Mentions in press and media 1
| Date | Title | Description | Source |
| - | Umecrine Cognition | “Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of d... | fastfounde... |